Aufrufe: 215
Audio
Teilen
London, April 21, 2026 at 7:30 a.m. GMT- Hamilton Global Opportunities plc (GB00BMDXQ672 - ALHGO) publishes its annual results for 2025, approved by the Board of Directors on April 17, 2026, and its annual financial report, which is available at the bottom of this page, the company's website (hamiltongo.eu) and on the AMF website.
Gustavo Perrotta, Founder and CEO of Hamilton Global Opportunities, said:
"2025 has been a transformational year for Hamilton Global Opportunities plc as we have been able to take the opportunity to successfully exit the majority of our investment in MIAX. The sale of the position in MIAX confirms the strategic objectives that we outlined to shareholders when we listed in 2021. The board of directors of HGO is now very pleased to be able to recommend a distribution of capital to shareholders by means of a dividend which will be subject to shareholder approval at our AGM on the 14th May. ”
Details of the main changes in the financial statements
Net assets amounted to €28.117 million, compared to €22.371 million on December 31, 2024.
At December 31, 2025, the cash position (including money market investments) was €8,430,037 compared to €1,000,096 on December 31, 2024.
(*- as restated)
The share price as of 31 December 2025, at €43.20 remains stable despite there being considerable volatility in financial markets throughout the year.
Highlights of the year 2025
MIAX - First successful exit from one of HGO’s early investments
AntariaPharma – continued investment in existing portfolio companies such as AntariaPharma
Dividend – proposal from the board of directors to distribute a divided to shareholders
NAV growth – Net Asset Value now exceeds market capitalisation of HGO for the first time
Cash – significant cash reserves of €8,430,037, including money market investments
About Hamilton Global Opportunities:
Hamilton Global Opportunities PLC (“HGO”) is an investment company listed on the Euronext Growth Market in Paris (ALHGO) focusing on investments in Tech, Fintech and MedTech principally in the United States and the EU. The HGO management team has significant relevant experience in structuring direct investments in the areas above mentioned. For more information, please visit: hamiltongo.eu
Contact
Attachments
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
